A detailed history of Buckingham Strategic Wealth, LLC transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Buckingham Strategic Wealth, LLC holds 17,820 shares of ABUS stock, worth $56,667. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,820
Previous 17,720 0.56%
Holding current value
$56,667
Previous $45,000 22.22%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$2.52 - $3.63 $252 - $363
100 Added 0.56%
17,820 $55,000
Q3 2022

Nov 07, 2022

SELL
$1.88 - $2.88 $20 - $31
-11 Reduced 0.06%
17,720 $34,000
Q2 2022

Aug 12, 2022

BUY
$1.98 - $3.17 $21 - $34
11 Added 0.06%
17,731 $48,000
Q1 2022

May 10, 2022

BUY
$2.42 - $3.98 $12,100 - $19,900
5,000 Added 39.31%
17,720 $53,000
Q3 2021

Nov 10, 2021

BUY
$2.65 - $4.62 $2,650 - $4,620
1,000 Added 8.53%
12,720 $55,000
Q2 2021

Aug 06, 2021

BUY
$2.5 - $3.51 $29,300 - $41,137
11,720 New
11,720 $36,000

Others Institutions Holding ABUS

About Arbutus Biopharma Corp


  • Ticker ABUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 149,951,008
  • Market Cap $477M
  • Description
  • Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...
More about ABUS
Track This Portfolio

Track Buckingham Strategic Wealth, LLC Portfolio

Follow Buckingham Strategic Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Buckingham Strategic Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Buckingham Strategic Wealth, LLC with notifications on news.